Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for UTHR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 -126.30M
March 31, 2026 1.426B
December 31, 2025 -99.00M
September 30, 2025 955.50M
June 30, 2025 -18.10M
March 31, 2025 -21.50M
December 31, 2024 -25.60M
September 30, 2024 -36.30M
June 30, 2024 -52.10M
March 31, 2024 953.90M
December 31, 2023 -7.30M
September 30, 2023 -7.80M
June 30, 2023 -24.70M
March 31, 2023 -64.80M
December 31, 2022 -55.50M
September 30, 2022 -7.30M
June 30, 2022 -23.90M
March 31, 2022 -7.60M
December 31, 2021 -7.70M
September 30, 2021 -16.80M
June 30, 2021 -10.80M
March 31, 2021 -20.30M
December 31, 2020 -7.90M
September 30, 2020 -5.70M
June 30, 2020 -21.70M
Date Value
March 31, 2020 -3.20M
December 31, 2019 0.00
September 30, 2019 -1.90M
June 30, 2019 -1.10M
March 31, 2019 -11.00M
December 31, 2018 -0.10M
September 30, 2018 -2.40M
June 30, 2018 -5.70M
March 31, 2018 -11.30M
December 31, 2017 -1.80M
September 30, 2017 -3.50M
June 30, 2017 246.40M
March 31, 2017 -35.10M
December 31, 2016 103.00M
September 30, 2016 132.50M
June 30, 2016 131.90M
March 31, 2016 120.60M
December 31, 2015 -10.25M
September 30, 2015 49.07M
June 30, 2015 170.24M
March 31, 2015 142.15M
December 31, 2014 65.81M
September 30, 2014 8.376M
June 30, 2014 266.13M
March 31, 2014 89.26M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Liquidia Corp. -1.443M
Insmed, Inc. -28.01M
MannKind Corp. -0.924M
Vertex Pharmaceuticals, Inc. 421.80M
BioMarin Pharmaceutical, Inc. -6.655M